GSK Canada Brand Strategy Document - Shingrix

This is a test brand strategy document for demonstration purposes.

Product: Shingrix Vaccine
Indication: Herpes Zoster (Shingles) Prevention
Target Population: Adults 50+ years in Canada

Strategic Objectives:
- Increase vaccination coverage from 23.5% to 35% by 2026
- Double the number of Canadians protected against Shingles
- Achieve 3% CAGR growth in eligible population coverage

Key Messages:
- Prevention is better than treatment
- Shingles can happen to anyone over 50
- Vaccination reduces risk by 97%

Target Audiences:
- Primary Care Physicians
- Specialists
- Pharmacy Networks
- Direct-to-Consumer

This document is for demo purposes only.